Cell‐Based Identification of New IDO1 Modulator Chemotypes-Reference-Cited by-同舟云学术

Cell‐Based Identification of New IDO1 Modulator Chemotypes

Published:2021-03-24 Issue:18 Volume:60 Page:9869-9874
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Hennes Elisabeth¹²,Lampe Philipp³,Dötsch Lara¹²,Bruning Nora²,Pulvermacher Lisa‐Marie²,Sievers Sonja³^ORCID,Ziegler Slava¹^ORCID,Waldmann Herbert¹²^ORCID

Affiliation:

1. Department of Chemical Biology Max Planck Institute of Molecular Physiology Otto-Hahn-Str. 11 44227 Dortmund Germany

2. Department of Chemical Biology Technical University of Dortmund Otto-Hahn-Strasse 6 44227 Dortmund Germany

3. Compound Management and Screening Center Otto-Hahn-Str.11 44227 Dortmund Germany

Funder

European Commission

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202016004

Reference40 articles.

1. Big opportunities for small molecules in immuno-oncology

2. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma.

4. Human Activated T Lymphocytes Modulate IDO Expression in Tumors through Th1/Th2 Balance

5. Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of 2-benzylsulfinyl-benzoxazoles as potent and selective indoleamine 2,3-dioxygenase 1 inhibitors to combat inflammation;Bioorganic Chemistry;2024-11

2. Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies;International Journal of Nanomedicine;2024-08

3. Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors;Bioorganic Chemistry;2024-07

4. Bioinformatics and system biology approach to identify potential common pathogenesis for COVID-19 infection and sarcopenia;Frontiers in Medicine;2024-06-24

5. Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator;Journal of Medicinal Chemistry;2024-03-12